Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

May 13, 2026 updated by: Johns Hopkins University

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma: A Pilot Feasibility Study

The purpose of this single-arm trial is to determine the feasibility of emotional awareness and expression therapy (EAET) for individuals with persistent pain following orthopedic trauma. As part of this study, participants will be asked to attend weekly EAET treatment sessions and complete assessments (including pre-treatment, post-treatment, and follow-up) consisting of questionnaires and sensory testing procedures.

Study Overview

Detailed Description

Orthopedic trauma, resulting in severe injuries such as multiple fractures or amputation, occurs in approximately 3 million people annually in the United States; about half of these people experience persistent pain and psychological distress (depression, anxiety, posttraumatic stress disorder [PTSD] symptoms) 6 to 12 months post injury. Pain and distress exacerbate one another, are likely to persist, and relate to disability: half of patients report substantial disability 7 years post trauma. Medical interventions such as surgery promote survival; however, there is an urgent need to develop targeted psychological interventions to treat these disabling symptoms.

Few psychological interventions are available to treat pain and distress following orthopedic trauma. Emotional Awareness and Expression Therapy (EAET) is an 8-week psychological intervention recently developed for chronic pain conditions characterized by central sensitization. EAET is unique in treating pain and mood by targeting emotion regulation processes related to traumatic life events. Such events are ubiquitous following orthopedic trauma and recent findings show that EAET results in improvements in pain and mood; thus, it may be uniquely effective to address the needs of orthopedic trauma survivors. However, there are documented barriers to implementing psychological interventions in this population, so the feasibility of EAET is unknown. The purpose of this study is to test the feasibility of delivery and assessment of EAET for orthopedic trauma survivors with persistent pain in a single-arm trial. As part of this study, participants will be asked to do the following things:

  • Attend EAET treatment with a mental health provider. Session will last around 60 minutes each.
  • Complete baseline, post-treatment, and follow-up assessments. These assessments will ask patients to complete questionnaires related to physical and emotional health, as well as receive sensory testing in order to examine pain processing. The questionnaires will take 20-25 minutes. The sensory testing procedures will take about 20 minutes.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Recruiting
        • Johns Hopkins School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • One or more acute orthopedic injuries
  • The patient sustained an orthopedic injury including, but not limited to:

    • Pelvic or acetabulum fracture
    • Open/displaced comminuted fracture of long bones
    • Upper extremity injuries with a major nerve involvement
    • Injuries with significant injuries to major blood vessels
    • Traumatic amputation of big toe, thumb, or proximal to the wrist or ankle.
  • Initial admission to the trauma or orthopedic center/service of the participating hospital OR all necessary screening and patient characteristic data available in medical record (determination based on information available at time of enrollment)
  • 18 years old or older
  • Received operative fixation for at least one acute orthopaedic injury at a participating hospital. Patients should be recruited at the time of primary injury, not revision or complication surgery
  • Average Brief Pain Inventory Score > 3/10
  • Presence of pain most days (> 3 days/week) for past three months

Exclusion Criteria:

  • peri-prosthetic fractures of the femur (regardless of etiology)
  • non-ambulatory due to an associated spinal cord injury
  • non-ambulatory pre-injury
  • currently pregnant
  • moderate or severe traumatic brain injury (TBI), as evidenced by intracranial hemorrhage present on admission CT
  • major amputation(s) of the upper or lower extremities
  • non-English speaking
  • Likely to have severe problems with maintaining follow-up for any of the following reasons:

    • The patient has been diagnosed with a severe psychiatric conditions
    • The patient has current alcohol and/or drug addiction based on medical record or patient self-report.
    • The patient is intellectually challenged without adequate family support
    • The patient lives outside the hospital's catchment area
    • The patient follow-up is planned at another medical center
    • The patient is a prisoner
    • The patient is homeless
    • Other

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Emotional Awareness and Expression Therapy
Emotional Awareness and Expression Therapy (EAET) is a non-pharmacological intervention designed to address persistent pain.
The goal of EAET is to increase awareness of uncomfortable emotions that are often linked to stressful past experiences (e.g., anger, sadness, fear) and learn adaptive ways to experience and express those emotions, in a safe and controlled environment. Core treatment components include pain education, drawing associations between the experience of pain and emotion, and experiencing and expressing emotions via imaginary, in vivo, and real life exposures. EAET will be delivered via 8, 60-minute, weekly psychotherapy visits.
Other Names:
  • EAET

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Enrollment
Time Frame: 24 months
Feasibility of enrollment will be measured by percentage of eligible patients who enroll in the study.
24 months
Feasibility of Retention
Time Frame: 24 months
Feasibility of retention will be measured by percentage of participants who are retained over the duration of the study.
24 months
Feasibility of Recruitment
Time Frame: 24 months
Feasibility of Recruitment will be measured by the enrollment of a full sample within two years of the start of the enrollment period.
24 months
Percentage of patient session attendance
Time Frame: 8 weeks
Percentage of patients who complete 6 of 8 total EAET sessions.
8 weeks
Therapist Fidelity (Questionnaire developed by study team)
Time Frame: 8 Weeks
Percentage of treatment fidelity across all treatment sessions (study therapist self-report using questionnaire developed by study team).
8 Weeks
Percentage of patients who indicate patient satisfaction and acceptability
Time Frame: 8 Weeks
Percentage of patients who indicate treatment acceptability on the Treatment Evaluation Inventory-Short Form. This is a 9-item measure and participants respond using a 1-5 point likert scale for a possible total range of 9-45. Higher scores indicate greater satisfaction and acceptability.
8 Weeks
Feasibility of Study Assessment
Time Frame: 1 Week
Measured by percent of pre-treatment assessments completed by participants.
1 Week
Feasibility of Study Assessment
Time Frame: 8 Weeks
Measured by percent of post-treatment assessments completed by participants.
8 Weeks
Feasibility of Study Assessment
Time Frame: 12 months
Measured by percent of follow-up assessments completed by participants.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rachel Aaron, PhD, Johns Hopkins University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2024

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

August 3, 2023

First Submitted That Met QC Criteria

August 3, 2023

First Posted (Actual)

August 14, 2023

Study Record Updates

Last Update Posted (Actual)

May 15, 2026

Last Update Submitted That Met QC Criteria

May 13, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00277255
  • K23HD104934 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Emotional Awareness and Expression Therapy

Subscribe